• ITVI.USA
    15,532.820
    -111.320
    -0.7%
  • OTLT.USA
    2.879
    0.005
    0.2%
  • OTRI.USA
    20.740
    0.050
    0.2%
  • OTVI.USA
    15,520.340
    -104.260
    -0.7%
  • TSTOPVRPM.ATLPHL
    2.820
    -0.100
    -3.4%
  • TSTOPVRPM.CHIATL
    3.580
    -0.100
    -2.7%
  • TSTOPVRPM.DALLAX
    1.260
    -0.030
    -2.3%
  • TSTOPVRPM.LAXDAL
    3.650
    0.030
    0.8%
  • TSTOPVRPM.PHLCHI
    2.330
    -0.090
    -3.7%
  • TSTOPVRPM.LAXSEA
    4.020
    -0.150
    -3.6%
  • WAIT.USA
    127.000
    -1.000
    -0.8%
  • ITVI.USA
    15,532.820
    -111.320
    -0.7%
  • OTLT.USA
    2.879
    0.005
    0.2%
  • OTRI.USA
    20.740
    0.050
    0.2%
  • OTVI.USA
    15,520.340
    -104.260
    -0.7%
  • TSTOPVRPM.ATLPHL
    2.820
    -0.100
    -3.4%
  • TSTOPVRPM.CHIATL
    3.580
    -0.100
    -2.7%
  • TSTOPVRPM.DALLAX
    1.260
    -0.030
    -2.3%
  • TSTOPVRPM.LAXDAL
    3.650
    0.030
    0.8%
  • TSTOPVRPM.PHLCHI
    2.330
    -0.090
    -3.7%
  • TSTOPVRPM.LAXSEA
    4.020
    -0.150
    -3.6%
  • WAIT.USA
    127.000
    -1.000
    -0.8%
FreightWaves TVMedically Necessary PodcastNews

Increasing cold chain capacity for new drugs — Medically Necessary

Companies prepare for more temperature controlled drugs

This podcast is brought to you by Ryder, the only fully integrated logistics & transportation provider in the industry. Ryder’s solutions cover the entire supply chain including warehousing, transportation logistics, e-commerce fulfillment, & last mile. Discover how Ryder can make you ever better at ryder.com.

On the third episode of Medically Necessary, reporter Matt Blois talks to Cold Chain Technologies CEO Ranjeet Banerjee.

Cold Chain Technologies provides logistics services for temperature sensitive materials in the life sciences industry and has been a big part of the effort to distribute COVID-19 vaccines.

The recent vaccine rollout has pushed the cold chain into the spotlight. But even before the pandemic, the growth of biologics and gene therapies — complex medicines that require sensitive temperature control — was driving demand for logistics services in the life sciences industry.

Banerjee explains the supply chain implications stemming from the growth of biologics and gene therapies. He also talks about how the pandemic affected the business of transporting sensitive drugs, as well as the industry’s future.

Subscribe to the newsletter here

Spotify

More FreightWaves Podcasts

We are glad you’re enjoying the content

Sign up for a free FreightWaves account today for unlimited access to all of our latest content

By signing in for the first time, I give consent for FreightWaves to send me event updates and news. I can unsubscribe from these emails at any time. For more information please see our Privacy Policy.